Increased hyaluronan and hyaluronidase production and hyaluronan degradation in injured aorta of insulin-resistant rats

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 6, 2000, Pages 1480-1487

  Chajara, Abdesslam ^a,c   Raoudi, Maha ^a   Delpech, Bertrand ^a   Leroy, Marcelle ^a   Basuyau, Jean Pierre ^a   Levesque, Hervé ^b  

^a CENTRE HENRI BECQUEREL   (France)

^b Dept de Médecine Interne Ctr Hosp Univ Rouen Boisguillaume   (France)

^c UNIVERSITÉ DE ROUEN   (France)

Author keywords

Aorta; Diabetes mellitus; Fructose feeding; Hyaluronan; Hyaluronidase; Hyperinsulinemia; Hypertriglyceridemia; Injury

Indexed keywords

DNA; FRUCTOSE; HYALURONIC ACID; HYALURONIDASE; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA INJURY; ARTERY INTIMA PROLIFERATION; ARTERY WALL; ARTICLE; BALLOON CATHETER; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA CONTENT; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MALE; MOLECULAR WEIGHT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; RESTENOSIS;

EID: 0034042021     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.6.1480     Document Type: Article

References (36)

1. Forrester JS, Fishbein M, Helfant R, Fagin J. A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. J Am Coll Cardiol. 1991;17:758-769.
2. Kip KE, Faxon DP, Detre KM, Yeh W, Kelsey SF, Currier JW. Coronary angioplasty in diabetic patients: the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation. 1996;94:1818-1825.
3. Stein B, Weintraub WS, Gebhart S, Cohen-Bernstein CL, Grosswald R, Liberman HA, Douglas JS, Morris DC, King SB. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation. 1995;91:979-989.
4. Asakura Y, Suzuki M, Nonogi H, Haze K, Sato A, Inada H, Okuda Y, Yamashita K, Harano Y. Restenosis after percutaneous transluminal coronary angioplasty in patients with non-insulin-dependent diabetes mellitus. J Cardiovasc Risk. 1998;5:331-334.
5. Kornowski R, Mintz GS, Kent KM, Pichard AD, Satler LF, Bucher TA, Hong MK, Popma JJ, Leon MB. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimai hyperplasia: a serial intravascular ultrasound study. Circulation. 1997;95:1366-1369.
6. Ridray S. Hyperinsulinemia and smooth muscle cell proliferation. Int J Obesity. 1995;19:S39-S51.
7. Haudenschild CC, Van Sickle W, Chobanian AV. Response of the aorta of the obese Zucker rat to injury. Arteriosclerosis. 1981;1:186-191.
8. Laurent TC, Fraser JRE. Hyaluronan. FASEB J. 1992;6:2397-2404.
9. Toole BP. Developmental role of hyaluronate. Connect Tissue Res. 1982; 10:93-100.
10. Delpech B, Girard N, Bertrand P, Courel MN, Chauzy C, Delpech A. Hyaluronan: fundamental principles and applications in cancer. J Intern Med. 1997;242:41-48.
11. Chajara A, Lévesque H, Courel MN, Chauzy C, Maingonnat C, Bertrand P, Delpech D. Hyaluronan and hyaluronectin production in injured rat thoracic aorta. Atherosclerosis. 1996;125:193-207.
12. Chajara A, Delpech D, Courel MN, Leroy M, Basuyau JP. Lévesque H. Effect of aging on neointima formation and hyaluronan, hyaluronidase and hyaluronectin production in injured rat aorta. Atherosclerosis. 1998;138:53-64.
13. Riessen R, Weight TN, Pastore C, Henley C, Isner JM. Distribution of hyaluronan during extracellular matrix remodeling in human restenotic arteries and balloon-injured rat carotid arteries. Circulation. 1996;93:1141-1147.
14. Savani RC, Turley EA. The role of hyaluronan and its receptors in restenosis after balloon angioplasty: development of potential therapy. Int J Tissue React. 1995;17:141-151.
15. Savani RC, Wang C, Yang B, Zhang S, Kinsella M, Wight TN, Stem R, Nance DM, Turley EA. Migration of bovine aortic smooth muscle cells after wounding injury: the role of hyaluronan and RHAMM. J Clin Invest. 1995;95:1158-1168.
16. Jain M, He Q, Lee WS, Kashik S, Foster LC, Tsai JC, Lee ME, Haber E. Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury. J Clin Invest. 1995;97:596-603.
17. Evanko SP, Angello JC, Wight TN. Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1999;19:1004-1013.
18. Bok SW. Hyaluronidase, from wound healing to cancer (II). Med Hypotheses. 1982;8:455-459.
19. Bok SW. Hyaluronidase, the fundamental cause of foetal growth. Med Hypotheses. 1980;6:1087-1096.
20. McGuire PG, Castellot JJ Jr, Orkin RW. Size-dependent hyaluronate degradation by cultured cells. J Cell Physiol. 1987;133:267-276.
21. Zavaroni I, Sander S, Scott S, Reaven GM. Effect of fructose feeding on insulin secretion and insulin action in the rat. Metabolism. 1980;29:970-973.
22. Zavaroni I, Chen YDI, Reaven GM. Studies of the mechanism of fructose-induced hypertriglyceridemia in rats. Metabolism. 1982;31:1077-1083.
23. Chajara A, Heudes D, Peronneau I, Jarnet J, Basset A, Capron L. Effects of heparinoids on the sclerotic reaction of thoracic aorta to injury: comparison between standard and low-molecular-weight heparins in vitro and in vivo. J Cardiovasc Pharmacol. 1994;23:995-1003.
24. Wolinsky H, Daly MM. A method for isolation of intima-media samples from arteries. Proc Soc Exp Biol Med. 1970;135:364-368.
25. Capron L, Bruneval E. Influence of applied stress on mitotic response of arteries to injury with a balloon catheter: quantitative study in rat thoracic aorta. Cardiovasc Res. 1989;23:941-948.
26. Burton KA. Study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J. 1956;62:315-323.
27. Delpech B, Bertrand P, Maingonnat C, Girard N, Chauzy C. Enzyme linked hyaluronectin: a unique reagent for hyaluronan assay and tissue location and for hyaluronidase activity detection. Anal Biochem. 1995;229:35-41.
28. Reissig JL, Strominger JL, Leloir LF. A modified colorimetric method for the estimation of N-acetylamino sugars. J Biol Chem. 1955;217:959-966.
29. Lévesque H, Girard N, Maingonnat C, Delpech A, Chauzy C, Tayot J, Courtois H, Delpech B. Localization and solubilization of hyaluronan and of the hyaluronan-binding protein hyaluronectin in human normal and arteriosclerotic arterial walls. Atherosclerosis. 1994;105:51-62.
30. Tobey TA, Mondon CE, Zavaroni I, Reaven GM. Mechanism of insulin resistance in fructose-fed rats. Metabolism. 1982;31:608-612.
31. Thorburn W, Storlien LH, Jenkins AB, Khouri S, Kraegen EW. Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. Am J Clin Nutr. 1989;49:1155-1163.
32. Geary RL, Nikkari ST, Wagner WD, Williams K, Adams MR, Dean RH. Wound healing: a paradigm for lumen narrowing after arterial reconstruction. J Vasc Surg. 1998;27:96-108.
33. Chajara A, Raoudi M, Delpech B, Courel MN, Leroy M, Basuyau JP, Lévesque H. Effects of diabetes and insulin treatment to diabetic rats on hyaluronan and hyaluronectin production in injured aorta. J Vasc Res. 1999;36:209-221.
34. Laurent TC, Laurent UBG, Fraser JRE. Serum hyaluronan as a disease marker. Ann Med. 1996;28:241-253.
35. West DC, Kumar S. The effect of hyaluronate and its oligosaccharides on endothelial cells proliferation and monolayer integrity. Exp Cell Res. 1989;183:179-196.
36. Trochon V, Mabilat C, Bertrand P, Legrand Y, Smadja-Joffe F, Soria C, Delpech B, Lu H. Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis. Int J Cancer. 1996;66:664-668.